openPR Logo
Press release

Anti-Venom Market Revenue Opportunies 2026 Estimated By Global Key Players Haffkine Bio-Pharmaceutical Corporation Ltd., Bharat Serums and Vaccines Ltd, Vins Bioproducts Limited, CSL Behring, Vacsera, Rare Therapeutics, Incepta Vaccine Ltd.

11-28-2018 02:12 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Anti-Venom Market

Anti-Venom Market

Anti-venom is a medication majorly used to treat snake bites and it can also be used to treat bites from scorpions, spiders or other reptiles. It is made by fractionating the blood of the donor (horse or sheep), which is hyperimmunized with snake venom. These products are available in either lyophilized or liquid forms. Anti-venom is the only effective therapy against snake bites and apart from lifesaving, they also save patients from cell and tissue necrosis, thus helping save vital organs. As per World Health Organization (WHO) fact sheet, 4.5 to 5.4 million people are bitten by snakes, every year, globally, out of which 1.8 to 2.7 million people develop clinical illnesses after snake bites and up to 81,000 to 1, 38,000 people die from such snake bites. Snakebite causes around 400,000 amputations and other permanent disabilities, annually.

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1249

South Asia and Africa are expected to drive growth of the anti-venom market, owing to higher incidence of snakebites

Growth of the anti-venom market is expected to be driven by South Asia and sub-Saharan African countries due to highest incidence of snake bites in these regions. As per WHO statistics, in India, 3.8 million people are bitten by snakes and 46,900 people die every year. In sub-Saharan Africa, around 7,000 to 20,000 people die annually from snake bites. Highest incidence is recorded in rural and peri-urban areas, where croppers and livestock workers live. However, growing urbanization is resulting in the loss of habitat for many snake species due to deforestation, thus drawing them towards area inhabited by humans, in turn, increasing the incidence of snakebites. The WHO, in June 2017, added snakebite to its priority list of neglected tropical disease, which would result in more focused effort to prevent death from snakebite, thus boosting growth of the anti-venom market. Increasing government funding for research and development and logistics in these countries is further drive growth of the global anti-venom market. Anti-venom product requires specialized infrastructure such as cold chain storage, which is not available adequately in highly prone regions such as Africa and Asia. This in turn, is hindering the supply of anti-venom products in these regions.

Key Players Present In The Anti-Venom Market:

Haffkine Bio-Pharmaceutical Corporation Ltd., Bharat Serums and Vaccines Ltd, Vins Bioproducts Limited, CSL Behring, Vacsera, Rare Therapeutics, Instituto Bioclon S.A.de C.V., and Incepta Vaccine Ltd.

Market Segmentation of the Global Anti-venom Market:

On The Basis Of Anti-Venom Type:

• Monovalent (Hyper immunizing venom obtained from single species)
• Polyvalent (Hyper immunizing venom from two or more species)

On The Basis Of Product Type:

• Snake anti-venom
• Scorpion anti-venom
• Spider anti-venom
• Other anti-venom products

On The Basis Of Distribution Channel:

• Hospitals
• Private clinics
• Ambulatory surgical centers

On The Basis Of Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1249

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Venom Market Revenue Opportunies 2026 Estimated By Global Key Players Haffkine Bio-Pharmaceutical Corporation Ltd., Bharat Serums and Vaccines Ltd, Vins Bioproducts Limited, CSL Behring, Vacsera, Rare Therapeutics, Incepta Vaccine Ltd. here

News-ID: 1405410 • Views: 339

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Africa

Frenchie Africa Introduction
Johannessburg, Gauteng, South Africa, 17 February 2021 – Frenchie Africa has announced the initiation of their website and Social Media channels to the public. Frenchie Africa will follow the journey of two French Bulldogs, Bakari and Jamani as they grow up in Africa. From their homebase, a small but cozy, custom-built log cabin in South Africa, Frenchie Africa will chronicle the lives of Bakari and Jamani and their owners Ross and
Baby Food in South Africa
Summary Although many consumers have been hard pressed over the last two years or so, as levels of consumer debt have mounted, the market for baby food has so far been fairly resilient, as purchases are predominantly still made by the upper income groups, who have suffered less than others from the difficult economic situation. Research published by Analytics Business Intelligence indicates that in 2011 some 41% of users of baby
14th Africa Independents Forum
The 14th Africa Independents Forum 2016, 25-26th May, gathers together leading independents and corporate players worldwide and from across Africa, both listed and unlisted, large and small, established and new entrants, and provides enhanced exposure to the wider Africa-wide upstream industry in oil, and gas, exploration and development, including issues in crude oil and financial markets, engaging equity financiers, banks, private equity and investors found on the AIM and LSE,
Vizocom Selects iSAT Africa as Its Africa C-band Partner
Vizocom, a leading global provider of satellite services, announced today that it has signed a partnership agreement with iSAT Africa to cooperate in providing satellite services and solutions. Sharjah, UAE, March 02, 2016 -- Vizocom, a leading global provider of satellite services, announced today that it has signed a partnership agreement with iSAT Africa to cooperate in providing satellite services and solutions such as data solutions including C-band VSAT services and
23rd Africa Oil Week
While the African Continent continues to attract a steady stream of oil and gas commitments in its fast-growing oil, gas-LNG and energy industry, our landmark Africa Oil Week 2016 event will again showcase Africa’s Governments, National Oil Companies, Licensing Agencies and corporate players shaping the continent’s future – in exploration and production/development, across new frontiers and established basins; onshore in the Rifts and offshore in the shelf and deep-water, providing
Vizocom Selects iSAT Africa as its Africa C-band Partner
Vizocom, a leading global provider of satellite services, announced today that it has signed a partnership agreement with iSAT Africa to cooperate in providing satellite services and solutions. Sharjah, UAE, February 29, 2016 -- Vizocom, a leading global provider of satellite services, announced today that it has signed a partnership agreement with iSAT Africa to cooperate in providing satellite services and solutions such as data solutions including C-band VSAT services and